Seegene, Inc. (096530.KQ) KOE

25,450.00

-250(-0.97%)

Updated at October 24 03:30PM

Currency In KRW

Seegene, Inc.

Address

Taewon Building

Seoul, 05548

Korea, Republic of

Phone

82 2 2240 4000

Sector

Healthcare

Industry

Medical - Specialties

Employees

63

First IPO Date

September 10, 2010

Key Executives

NameTitlePayYear Born
Dr. Richard S. Creager Ph.D.Chief Executive Officer of Seegene Technologies01953
Dr. Jong-Yoon ChunFounder, Chief Executive Officer, Chief Technology Officer & Director01957
Mr. Jin-Soo ChoiExecutive Vice President & Director01952
Jong-Gi CheonVice President and Chairman of Seegene Medical Foundation01962

Description

Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of six SNPs in factor II, factor V, and MTHFR genes; BRAF mutation characteristic for papillary thyroid carcinoma from samples of thyroid tissue, fine needle aspiration biopsy, H&E slides, and paraffin-embedded tissues; Apolipoprotein E genotypes; and BCR/ABL fusion gene from blood and whole bone marrow. In addition, it offers PCR machines; vial cap management systems; nucleic acid extraction systems; automated liquid handling workstations from nucleic acid extraction to PCR setup; and real-time PCR detection systems. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.